nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ALB—atherosclerosis	0.141	1	CbGaD
Liotrix—SLCO1B3—Rosuvastatin—atherosclerosis	0.0724	0.11	CbGbCtD
Liotrix—SLCO1B3—Pravastatin—atherosclerosis	0.0658	0.1	CbGbCtD
Liotrix—SLCO1A2—Rosuvastatin—atherosclerosis	0.0447	0.0678	CbGbCtD
Liotrix—SLCO1B1—Ezetimibe—atherosclerosis	0.0421	0.064	CbGbCtD
Liotrix—SLCO1B1—Rosuvastatin—atherosclerosis	0.0421	0.064	CbGbCtD
Liotrix—SLCO1A2—Simvastatin—atherosclerosis	0.0415	0.0631	CbGbCtD
Liotrix—SLCO1A2—Lovastatin—atherosclerosis	0.0406	0.0617	CbGbCtD
Liotrix—SLCO1A2—Pravastatin—atherosclerosis	0.0406	0.0617	CbGbCtD
Liotrix—SLCO1B1—Simvastatin—atherosclerosis	0.0392	0.0595	CbGbCtD
Liotrix—SLCO1B1—Lovastatin—atherosclerosis	0.0383	0.0582	CbGbCtD
Liotrix—SLCO1B1—Pravastatin—atherosclerosis	0.0383	0.0582	CbGbCtD
Liotrix—SLC22A8—Pravastatin—atherosclerosis	0.0354	0.0537	CbGbCtD
Liotrix—ALB—Rosuvastatin—atherosclerosis	0.0231	0.035	CbGbCtD
Liotrix—CYP2C8—Simvastatin—atherosclerosis	0.0166	0.0252	CbGbCtD
Liotrix—CYP2C8—Lovastatin—atherosclerosis	0.0162	0.0246	CbGbCtD
Liotrix—CYP2C8—Pravastatin—atherosclerosis	0.0162	0.0246	CbGbCtD
Liotrix—ABCB1—Ezetimibe—atherosclerosis	0.0121	0.0183	CbGbCtD
Liotrix—ABCB1—Simvastatin—atherosclerosis	0.0112	0.017	CbGbCtD
Liotrix—ABCB1—Lovastatin—atherosclerosis	0.011	0.0167	CbGbCtD
Liotrix—ABCB1—Pravastatin—atherosclerosis	0.011	0.0167	CbGbCtD
Liotrix—Distention—Pravastatin—atherosclerosis	0.0036	0.0378	CcSEcCtD
Liotrix—Tracheobronchitis—Pravastatin—atherosclerosis	0.00281	0.0295	CcSEcCtD
Liotrix—Warmth—Niacin—atherosclerosis	0.00271	0.0284	CcSEcCtD
Liotrix—Tenderness—Lovastatin—atherosclerosis	0.00115	0.0121	CcSEcCtD
Liotrix—Necrosis—Niacin—atherosclerosis	0.0011	0.0115	CcSEcCtD
Liotrix—Feeling hot—Niacin—atherosclerosis	0.0011	0.0115	CcSEcCtD
Liotrix—Tenderness—Simvastatin—atherosclerosis	0.00108	0.0113	CcSEcCtD
Liotrix—Tingling sensation—Niacin—atherosclerosis	0.00107	0.0112	CcSEcCtD
Liotrix—Tenderness—Pravastatin—atherosclerosis	0.000973	0.0102	CcSEcCtD
Liotrix—Renal failure acute—Rosuvastatin—atherosclerosis	0.000931	0.00977	CcSEcCtD
Liotrix—Muscle twitching—Niacin—atherosclerosis	0.000878	0.00921	CcSEcCtD
Liotrix—Fluid retention—Niacin—atherosclerosis	0.000818	0.00858	CcSEcCtD
Liotrix—Swelling—Simvastatin—atherosclerosis	0.000772	0.0081	CcSEcCtD
Liotrix—Muscular weakness—Rosuvastatin—atherosclerosis	0.000758	0.00795	CcSEcCtD
Liotrix—Bronchitis—Rosuvastatin—atherosclerosis	0.000714	0.00749	CcSEcCtD
Liotrix—Renal failure acute—Pravastatin—atherosclerosis	0.000667	0.007	CcSEcCtD
Liotrix—Muscular weakness—Ezetimibe—atherosclerosis	0.00063	0.00661	CcSEcCtD
Liotrix—Affect lability—Pravastatin—atherosclerosis	0.000606	0.00636	CcSEcCtD
Liotrix—Muscular weakness—Simvastatin—atherosclerosis	0.000601	0.0063	CcSEcCtD
Liotrix—Mood swings—Pravastatin—atherosclerosis	0.000584	0.00612	CcSEcCtD
Liotrix—THRA—connective tissue—atherosclerosis	0.000576	0.0722	CbGeAlD
Liotrix—Bronchitis—Simvastatin—atherosclerosis	0.000566	0.00594	CcSEcCtD
Liotrix—Muscular weakness—Niacin—atherosclerosis	0.000552	0.00579	CcSEcCtD
Liotrix—Abdominal distension—Niacin—atherosclerosis	0.000544	0.00571	CcSEcCtD
Liotrix—Muscular weakness—Pravastatin—atherosclerosis	0.000543	0.0057	CcSEcCtD
Liotrix—Dysphagia—Niacin—atherosclerosis	0.000541	0.00567	CcSEcCtD
Liotrix—Abdominal distension—Pravastatin—atherosclerosis	0.000536	0.00562	CcSEcCtD
Liotrix—Arrhythmia—Rosuvastatin—atherosclerosis	0.000531	0.00557	CcSEcCtD
Liotrix—Angina pectoris—Niacin—atherosclerosis	0.000527	0.00553	CcSEcCtD
Liotrix—Bronchitis—Niacin—atherosclerosis	0.00052	0.00545	CcSEcCtD
Liotrix—Sweating increased—Pravastatin—atherosclerosis	0.000519	0.00544	CcSEcCtD
Liotrix—Angina pectoris—Pravastatin—atherosclerosis	0.000519	0.00544	CcSEcCtD
Liotrix—Flatulence—Rosuvastatin—atherosclerosis	0.00051	0.00535	CcSEcCtD
Liotrix—SERPINA7—liver—atherosclerosis	0.000501	0.0629	CbGeAlD
Liotrix—THRA—cardiovascular system—atherosclerosis	0.000501	0.0629	CbGeAlD
Liotrix—Weight decreased—Pravastatin—atherosclerosis	0.000482	0.00505	CcSEcCtD
Liotrix—Angioedema—Rosuvastatin—atherosclerosis	0.000473	0.00496	CcSEcCtD
Liotrix—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000468	0.00491	CcSEcCtD
Liotrix—Flushing—Lovastatin—atherosclerosis	0.000468	0.00491	CcSEcCtD
Liotrix—Myocardial infarction—Pravastatin—atherosclerosis	0.000465	0.00488	CcSEcCtD
Liotrix—Sweating—Niacin—atherosclerosis	0.000462	0.00485	CcSEcCtD
Liotrix—Flushing—Ezetimibe—atherosclerosis	0.000459	0.00481	CcSEcCtD
Liotrix—Alopecia—Lovastatin—atherosclerosis	0.000445	0.00467	CcSEcCtD
Liotrix—THRA—adipose tissue—atherosclerosis	0.000442	0.0554	CbGeAlD
Liotrix—THRB—adipose tissue—atherosclerosis	0.000442	0.0554	CbGeAlD
Liotrix—Arthralgia—Rosuvastatin—atherosclerosis	0.000441	0.00462	CcSEcCtD
Liotrix—Flushing—Simvastatin—atherosclerosis	0.000437	0.00459	CcSEcCtD
Liotrix—Alopecia—Ezetimibe—atherosclerosis	0.000437	0.00458	CcSEcCtD
Liotrix—Flatulence—Lovastatin—atherosclerosis	0.000432	0.00453	CcSEcCtD
Liotrix—Hypoaesthesia—Niacin—atherosclerosis	0.000431	0.00452	CcSEcCtD
Liotrix—Dysgeusia—Lovastatin—atherosclerosis	0.00043	0.00451	CcSEcCtD
Liotrix—TTR—connective tissue—atherosclerosis	0.000428	0.0537	CbGeAlD
Liotrix—Confusional state—Rosuvastatin—atherosclerosis	0.000426	0.00447	CcSEcCtD
Liotrix—Hypoaesthesia—Pravastatin—atherosclerosis	0.000424	0.00445	CcSEcCtD
Liotrix—Flatulence—Ezetimibe—atherosclerosis	0.000424	0.00445	CcSEcCtD
Liotrix—Infection—Rosuvastatin—atherosclerosis	0.00042	0.0044	CcSEcCtD
Liotrix—Alopecia—Simvastatin—atherosclerosis	0.000417	0.00437	CcSEcCtD
Liotrix—Vision blurred—Lovastatin—atherosclerosis	0.000413	0.00434	CcSEcCtD
Liotrix—Tremor—Lovastatin—atherosclerosis	0.000411	0.00431	CcSEcCtD
Liotrix—Flatulence—Simvastatin—atherosclerosis	0.000404	0.00424	CcSEcCtD
Liotrix—Dysgeusia—Simvastatin—atherosclerosis	0.000402	0.00421	CcSEcCtD
Liotrix—Flushing—Niacin—atherosclerosis	0.000402	0.00421	CcSEcCtD
Liotrix—Angioedema—Lovastatin—atherosclerosis	0.000401	0.0042	CcSEcCtD
Liotrix—SLC16A2—adipose tissue—atherosclerosis	0.0004	0.0502	CbGeAlD
Liotrix—Flushing—Pravastatin—atherosclerosis	0.000395	0.00415	CcSEcCtD
Liotrix—Angioedema—Ezetimibe—atherosclerosis	0.000393	0.00412	CcSEcCtD
Liotrix—Vision blurred—Simvastatin—atherosclerosis	0.000387	0.00406	CcSEcCtD
Liotrix—Arrhythmia—Niacin—atherosclerosis	0.000387	0.00406	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000385	0.00404	CcSEcCtD
Liotrix—Tremor—Simvastatin—atherosclerosis	0.000384	0.00403	CcSEcCtD
Liotrix—Alopecia—Niacin—atherosclerosis	0.000382	0.00401	CcSEcCtD
Liotrix—Insomnia—Rosuvastatin—atherosclerosis	0.000382	0.00401	CcSEcCtD
Liotrix—Arrhythmia—Pravastatin—atherosclerosis	0.000381	0.00399	CcSEcCtD
Liotrix—Palpitations—Ezetimibe—atherosclerosis	0.00038	0.00399	CcSEcCtD
Liotrix—Paraesthesia—Rosuvastatin—atherosclerosis	0.000379	0.00398	CcSEcCtD
Liotrix—Alopecia—Pravastatin—atherosclerosis	0.000377	0.00395	CcSEcCtD
Liotrix—Angioedema—Simvastatin—atherosclerosis	0.000375	0.00393	CcSEcCtD
Liotrix—Chest pain—Lovastatin—atherosclerosis	0.000373	0.00392	CcSEcCtD
Liotrix—Arthralgia—Lovastatin—atherosclerosis	0.000373	0.00392	CcSEcCtD
Liotrix—TTR—cardiovascular system—atherosclerosis	0.000372	0.0467	CbGeAlD
Liotrix—Anxiety—Lovastatin—atherosclerosis	0.000372	0.0039	CcSEcCtD
Liotrix—Hypertension—Ezetimibe—atherosclerosis	0.000371	0.0039	CcSEcCtD
Liotrix—Flatulence—Niacin—atherosclerosis	0.000371	0.00389	CcSEcCtD
Liotrix—Tension—Niacin—atherosclerosis	0.00037	0.00388	CcSEcCtD
Liotrix—SLCO1C1—adipose tissue—atherosclerosis	0.000367	0.0461	CbGeAlD
Liotrix—Chest pain—Ezetimibe—atherosclerosis	0.000366	0.00384	CcSEcCtD
Liotrix—Arthralgia—Ezetimibe—atherosclerosis	0.000366	0.00384	CcSEcCtD
Liotrix—Nervousness—Niacin—atherosclerosis	0.000366	0.00384	CcSEcCtD
Liotrix—Flatulence—Pravastatin—atherosclerosis	0.000366	0.00383	CcSEcCtD
Liotrix—Tension—Pravastatin—atherosclerosis	0.000364	0.00382	CcSEcCtD
Liotrix—Dysgeusia—Pravastatin—atherosclerosis	0.000363	0.00381	CcSEcCtD
Liotrix—Constipation—Rosuvastatin—atherosclerosis	0.000361	0.00379	CcSEcCtD
Liotrix—Confusional state—Lovastatin—atherosclerosis	0.000361	0.00379	CcSEcCtD
Liotrix—Nervousness—Pravastatin—atherosclerosis	0.00036	0.00378	CcSEcCtD
Liotrix—Anaphylactic shock—Lovastatin—atherosclerosis	0.000358	0.00376	CcSEcCtD
Liotrix—Infection—Lovastatin—atherosclerosis	0.000356	0.00373	CcSEcCtD
Liotrix—Vision blurred—Niacin—atherosclerosis	0.000355	0.00372	CcSEcCtD
Liotrix—Confusional state—Ezetimibe—atherosclerosis	0.000354	0.00371	CcSEcCtD
Liotrix—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000351	0.00368	CcSEcCtD
Liotrix—Vision blurred—Pravastatin—atherosclerosis	0.00035	0.00367	CcSEcCtD
Liotrix—Arthralgia—Simvastatin—atherosclerosis	0.000349	0.00366	CcSEcCtD
Liotrix—Chest pain—Simvastatin—atherosclerosis	0.000349	0.00366	CcSEcCtD
Liotrix—Infection—Ezetimibe—atherosclerosis	0.000349	0.00366	CcSEcCtD
Liotrix—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000348	0.00365	CcSEcCtD
Liotrix—Anxiety—Simvastatin—atherosclerosis	0.000348	0.00365	CcSEcCtD
Liotrix—Tremor—Pravastatin—atherosclerosis	0.000348	0.00365	CcSEcCtD
Liotrix—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000345	0.00362	CcSEcCtD
Liotrix—Angioedema—Niacin—atherosclerosis	0.000344	0.00361	CcSEcCtD
Liotrix—Anorexia—Lovastatin—atherosclerosis	0.000341	0.00358	CcSEcCtD
Liotrix—Angioedema—Pravastatin—atherosclerosis	0.000339	0.00356	CcSEcCtD
Liotrix—Syncope—Niacin—atherosclerosis	0.000338	0.00354	CcSEcCtD
Liotrix—Confusional state—Simvastatin—atherosclerosis	0.000338	0.00354	CcSEcCtD
Liotrix—Urticaria—Rosuvastatin—atherosclerosis	0.000336	0.00352	CcSEcCtD
Liotrix—Anaphylactic shock—Simvastatin—atherosclerosis	0.000335	0.00351	CcSEcCtD
Liotrix—Oedema—Simvastatin—atherosclerosis	0.000335	0.00351	CcSEcCtD
Liotrix—Abdominal pain—Rosuvastatin—atherosclerosis	0.000334	0.0035	CcSEcCtD
Liotrix—Palpitations—Niacin—atherosclerosis	0.000333	0.00349	CcSEcCtD
Liotrix—Infection—Simvastatin—atherosclerosis	0.000333	0.00349	CcSEcCtD
Liotrix—Loss of consciousness—Niacin—atherosclerosis	0.000331	0.00347	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000326	0.00342	CcSEcCtD
Liotrix—Insomnia—Lovastatin—atherosclerosis	0.000324	0.0034	CcSEcCtD
Liotrix—SLCO4C1—liver—atherosclerosis	0.000323	0.0405	CbGeAlD
Liotrix—Paraesthesia—Lovastatin—atherosclerosis	0.000321	0.00337	CcSEcCtD
Liotrix—Arthralgia—Niacin—atherosclerosis	0.000321	0.00336	CcSEcCtD
Liotrix—Hypertension—Pravastatin—atherosclerosis	0.00032	0.00336	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00032	0.00336	CcSEcCtD
Liotrix—Anorexia—Simvastatin—atherosclerosis	0.000319	0.00335	CcSEcCtD
Liotrix—Dyspnoea—Lovastatin—atherosclerosis	0.000319	0.00335	CcSEcCtD
Liotrix—Insomnia—Ezetimibe—atherosclerosis	0.000318	0.00333	CcSEcCtD
Liotrix—Arthralgia—Pravastatin—atherosclerosis	0.000316	0.00331	CcSEcCtD
Liotrix—Chest pain—Pravastatin—atherosclerosis	0.000316	0.00331	CcSEcCtD
Liotrix—Paraesthesia—Ezetimibe—atherosclerosis	0.000315	0.00331	CcSEcCtD
Liotrix—Anxiety—Pravastatin—atherosclerosis	0.000315	0.0033	CcSEcCtD
Liotrix—SLCO1B3—liver—atherosclerosis	0.000314	0.0394	CbGeAlD
Liotrix—Dyspnoea—Ezetimibe—atherosclerosis	0.000313	0.00328	CcSEcCtD
Liotrix—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000311	0.00326	CcSEcCtD
Liotrix—Decreased appetite—Lovastatin—atherosclerosis	0.000311	0.00326	CcSEcCtD
Liotrix—THRA—liver—atherosclerosis	0.00031	0.0389	CbGeAlD
Liotrix—THRB—liver—atherosclerosis	0.00031	0.0389	CbGeAlD
Liotrix—Fatigue—Lovastatin—atherosclerosis	0.000309	0.00324	CcSEcCtD
Liotrix—Anaphylactic shock—Niacin—atherosclerosis	0.000307	0.00323	CcSEcCtD
Liotrix—Oedema—Niacin—atherosclerosis	0.000307	0.00323	CcSEcCtD
Liotrix—Constipation—Lovastatin—atherosclerosis	0.000306	0.00321	CcSEcCtD
Liotrix—Confusional state—Pravastatin—atherosclerosis	0.000305	0.0032	CcSEcCtD
Liotrix—Decreased appetite—Ezetimibe—atherosclerosis	0.000305	0.0032	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000305	0.0032	CcSEcCtD
Liotrix—Asthenia—Rosuvastatin—atherosclerosis	0.000303	0.00318	CcSEcCtD
Liotrix—Insomnia—Simvastatin—atherosclerosis	0.000303	0.00318	CcSEcCtD
Liotrix—Oedema—Pravastatin—atherosclerosis	0.000303	0.00318	CcSEcCtD
Liotrix—Anaphylactic shock—Pravastatin—atherosclerosis	0.000303	0.00318	CcSEcCtD
Liotrix—Fatigue—Ezetimibe—atherosclerosis	0.000303	0.00318	CcSEcCtD
Liotrix—Shock—Niacin—atherosclerosis	0.000303	0.00317	CcSEcCtD
Liotrix—Infection—Pravastatin—atherosclerosis	0.000301	0.00316	CcSEcCtD
Liotrix—Paraesthesia—Simvastatin—atherosclerosis	0.000301	0.00315	CcSEcCtD
Liotrix—Constipation—Ezetimibe—atherosclerosis	0.0003	0.00315	CcSEcCtD
Liotrix—Tachycardia—Niacin—atherosclerosis	0.0003	0.00315	CcSEcCtD
Liotrix—Pruritus—Rosuvastatin—atherosclerosis	0.000299	0.00314	CcSEcCtD
Liotrix—Dyspnoea—Simvastatin—atherosclerosis	0.000299	0.00313	CcSEcCtD
Liotrix—Hyperhidrosis—Niacin—atherosclerosis	0.000297	0.00312	CcSEcCtD
Liotrix—Feeling abnormal—Lovastatin—atherosclerosis	0.000295	0.00309	CcSEcCtD
Liotrix—SLCO4A1—adipose tissue—atherosclerosis	0.000294	0.0369	CbGeAlD
Liotrix—Anorexia—Niacin—atherosclerosis	0.000293	0.00307	CcSEcCtD
Liotrix—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000293	0.00307	CcSEcCtD
Liotrix—Hyperhidrosis—Pravastatin—atherosclerosis	0.000293	0.00307	CcSEcCtD
Liotrix—Decreased appetite—Simvastatin—atherosclerosis	0.000291	0.00305	CcSEcCtD
Liotrix—Feeling abnormal—Ezetimibe—atherosclerosis	0.000289	0.00304	CcSEcCtD
Liotrix—Diarrhoea—Rosuvastatin—atherosclerosis	0.000289	0.00303	CcSEcCtD
Liotrix—Fatigue—Simvastatin—atherosclerosis	0.000289	0.00303	CcSEcCtD
Liotrix—Anorexia—Pravastatin—atherosclerosis	0.000289	0.00303	CcSEcCtD
Liotrix—Hypotension—Niacin—atherosclerosis	0.000287	0.00301	CcSEcCtD
Liotrix—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000287	0.00301	CcSEcCtD
Liotrix—Constipation—Simvastatin—atherosclerosis	0.000286	0.003	CcSEcCtD
Liotrix—Urticaria—Lovastatin—atherosclerosis	0.000284	0.00298	CcSEcCtD
Liotrix—Body temperature increased—Lovastatin—atherosclerosis	0.000283	0.00297	CcSEcCtD
Liotrix—Abdominal pain—Lovastatin—atherosclerosis	0.000283	0.00297	CcSEcCtD
Liotrix—SLC16A2—liver—atherosclerosis	0.000281	0.0352	CbGeAlD
Liotrix—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00028	0.00294	CcSEcCtD
Liotrix—Dizziness—Rosuvastatin—atherosclerosis	0.000279	0.00293	CcSEcCtD
Liotrix—Urticaria—Ezetimibe—atherosclerosis	0.000279	0.00293	CcSEcCtD
Liotrix—Insomnia—Niacin—atherosclerosis	0.000278	0.00292	CcSEcCtD
Liotrix—Body temperature increased—Ezetimibe—atherosclerosis	0.000278	0.00291	CcSEcCtD
Liotrix—Abdominal pain—Ezetimibe—atherosclerosis	0.000278	0.00291	CcSEcCtD
Liotrix—Paraesthesia—Niacin—atherosclerosis	0.000276	0.0029	CcSEcCtD
Liotrix—Feeling abnormal—Simvastatin—atherosclerosis	0.000276	0.00289	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000276	0.00289	CcSEcCtD
Liotrix—Dyspnoea—Niacin—atherosclerosis	0.000274	0.00288	CcSEcCtD
Liotrix—SLC10A1—liver—atherosclerosis	0.000274	0.0344	CbGeAlD
Liotrix—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000274	0.00287	CcSEcCtD
Liotrix—Insomnia—Pravastatin—atherosclerosis	0.000274	0.00287	CcSEcCtD
Liotrix—Paraesthesia—Pravastatin—atherosclerosis	0.000272	0.00285	CcSEcCtD
Liotrix—Dyspnoea—Pravastatin—atherosclerosis	0.00027	0.00283	CcSEcCtD
Liotrix—Decreased appetite—Niacin—atherosclerosis	0.000267	0.0028	CcSEcCtD
Liotrix—Rash—Rosuvastatin—atherosclerosis	0.000266	0.00279	CcSEcCtD
Liotrix—Dermatitis—Rosuvastatin—atherosclerosis	0.000266	0.00279	CcSEcCtD
Liotrix—Urticaria—Simvastatin—atherosclerosis	0.000266	0.00279	CcSEcCtD
Liotrix—Body temperature increased—Simvastatin—atherosclerosis	0.000265	0.00278	CcSEcCtD
Liotrix—Abdominal pain—Simvastatin—atherosclerosis	0.000265	0.00278	CcSEcCtD
Liotrix—Headache—Rosuvastatin—atherosclerosis	0.000265	0.00278	CcSEcCtD
Liotrix—Hypersensitivity—Lovastatin—atherosclerosis	0.000264	0.00277	CcSEcCtD
Liotrix—Decreased appetite—Pravastatin—atherosclerosis	0.000263	0.00276	CcSEcCtD
Liotrix—Fatigue—Pravastatin—atherosclerosis	0.000261	0.00274	CcSEcCtD
Liotrix—Constipation—Pravastatin—atherosclerosis	0.000259	0.00272	CcSEcCtD
Liotrix—Hypersensitivity—Ezetimibe—atherosclerosis	0.000259	0.00271	CcSEcCtD
Liotrix—SLC16A10—adipose tissue—atherosclerosis	0.000258	0.0324	CbGeAlD
Liotrix—Asthenia—Lovastatin—atherosclerosis	0.000257	0.00269	CcSEcCtD
Liotrix—Pruritus—Lovastatin—atherosclerosis	0.000253	0.00266	CcSEcCtD
Liotrix—Asthenia—Ezetimibe—atherosclerosis	0.000252	0.00264	CcSEcCtD
Liotrix—Gastrointestinal pain—Niacin—atherosclerosis	0.000251	0.00264	CcSEcCtD
Liotrix—Nausea—Rosuvastatin—atherosclerosis	0.000251	0.00263	CcSEcCtD
Liotrix—Feeling abnormal—Pravastatin—atherosclerosis	0.000249	0.00262	CcSEcCtD
Liotrix—Pruritus—Ezetimibe—atherosclerosis	0.000248	0.00261	CcSEcCtD
Liotrix—Levothyroxine—ALB—atherosclerosis	0.000248	0.584	CrCbGaD
Liotrix—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000248	0.0026	CcSEcCtD
Liotrix—Hypersensitivity—Simvastatin—atherosclerosis	0.000247	0.00259	CcSEcCtD
Liotrix—Diarrhoea—Lovastatin—atherosclerosis	0.000245	0.00257	CcSEcCtD
Liotrix—Urticaria—Niacin—atherosclerosis	0.000244	0.00256	CcSEcCtD
Liotrix—Body temperature increased—Niacin—atherosclerosis	0.000243	0.00255	CcSEcCtD
Liotrix—Abdominal pain—Niacin—atherosclerosis	0.000243	0.00255	CcSEcCtD
Liotrix—Urticaria—Pravastatin—atherosclerosis	0.000241	0.00252	CcSEcCtD
Liotrix—Asthenia—Simvastatin—atherosclerosis	0.00024	0.00252	CcSEcCtD
Liotrix—Diarrhoea—Ezetimibe—atherosclerosis	0.00024	0.00252	CcSEcCtD
Liotrix—Body temperature increased—Pravastatin—atherosclerosis	0.000239	0.00251	CcSEcCtD
Liotrix—Abdominal pain—Pravastatin—atherosclerosis	0.000239	0.00251	CcSEcCtD
Liotrix—Pruritus—Simvastatin—atherosclerosis	0.000237	0.00249	CcSEcCtD
Liotrix—Dizziness—Lovastatin—atherosclerosis	0.000237	0.00248	CcSEcCtD
Liotrix—Dizziness—Ezetimibe—atherosclerosis	0.000232	0.00244	CcSEcCtD
Liotrix—TTR—liver—atherosclerosis	0.00023	0.0289	CbGeAlD
Liotrix—Diarrhoea—Simvastatin—atherosclerosis	0.000229	0.0024	CcSEcCtD
Liotrix—Vomiting—Lovastatin—atherosclerosis	0.000228	0.00239	CcSEcCtD
Liotrix—Hypersensitivity—Niacin—atherosclerosis	0.000227	0.00238	CcSEcCtD
Liotrix—Rash—Lovastatin—atherosclerosis	0.000226	0.00237	CcSEcCtD
Liotrix—Dermatitis—Lovastatin—atherosclerosis	0.000226	0.00237	CcSEcCtD
Liotrix—Headache—Lovastatin—atherosclerosis	0.000224	0.00235	CcSEcCtD
Liotrix—Vomiting—Ezetimibe—atherosclerosis	0.000223	0.00234	CcSEcCtD
Liotrix—Hypersensitivity—Pravastatin—atherosclerosis	0.000223	0.00234	CcSEcCtD
Liotrix—Dizziness—Simvastatin—atherosclerosis	0.000221	0.00232	CcSEcCtD
Liotrix—Rash—Ezetimibe—atherosclerosis	0.000221	0.00232	CcSEcCtD
Liotrix—Dermatitis—Ezetimibe—atherosclerosis	0.000221	0.00232	CcSEcCtD
Liotrix—Asthenia—Niacin—atherosclerosis	0.000221	0.00231	CcSEcCtD
Liotrix—Headache—Ezetimibe—atherosclerosis	0.00022	0.00231	CcSEcCtD
Liotrix—Pruritus—Niacin—atherosclerosis	0.000218	0.00228	CcSEcCtD
Liotrix—Asthenia—Pravastatin—atherosclerosis	0.000217	0.00228	CcSEcCtD
Liotrix—Pruritus—Pravastatin—atherosclerosis	0.000214	0.00225	CcSEcCtD
Liotrix—Vomiting—Simvastatin—atherosclerosis	0.000213	0.00223	CcSEcCtD
Liotrix—Nausea—Lovastatin—atherosclerosis	0.000213	0.00223	CcSEcCtD
Liotrix—Rash—Simvastatin—atherosclerosis	0.000211	0.00221	CcSEcCtD
Liotrix—Dermatitis—Simvastatin—atherosclerosis	0.000211	0.00221	CcSEcCtD
Liotrix—Diarrhoea—Niacin—atherosclerosis	0.00021	0.00221	CcSEcCtD
Liotrix—Headache—Simvastatin—atherosclerosis	0.00021	0.0022	CcSEcCtD
Liotrix—Nausea—Ezetimibe—atherosclerosis	0.000209	0.00219	CcSEcCtD
Liotrix—Diarrhoea—Pravastatin—atherosclerosis	0.000207	0.00217	CcSEcCtD
Liotrix—SLCO4A1—liver—atherosclerosis	0.000206	0.0259	CbGeAlD
Liotrix—Dizziness—Niacin—atherosclerosis	0.000203	0.00213	CcSEcCtD
Liotrix—Dizziness—Pravastatin—atherosclerosis	0.0002	0.0021	CcSEcCtD
Liotrix—Nausea—Simvastatin—atherosclerosis	0.000199	0.00209	CcSEcCtD
Liotrix—Vomiting—Niacin—atherosclerosis	0.000195	0.00205	CcSEcCtD
Liotrix—Rash—Niacin—atherosclerosis	0.000194	0.00203	CcSEcCtD
Liotrix—Dermatitis—Niacin—atherosclerosis	0.000194	0.00203	CcSEcCtD
Liotrix—Headache—Niacin—atherosclerosis	0.000193	0.00202	CcSEcCtD
Liotrix—Vomiting—Pravastatin—atherosclerosis	0.000192	0.00202	CcSEcCtD
Liotrix—Rash—Pravastatin—atherosclerosis	0.000191	0.002	CcSEcCtD
Liotrix—Dermatitis—Pravastatin—atherosclerosis	0.000191	0.002	CcSEcCtD
Liotrix—Headache—Pravastatin—atherosclerosis	0.00019	0.00199	CcSEcCtD
Liotrix—Nausea—Niacin—atherosclerosis	0.000183	0.00192	CcSEcCtD
Liotrix—SLCO1B1—liver—atherosclerosis	0.000182	0.0228	CbGeAlD
Liotrix—SLC16A10—liver—atherosclerosis	0.000181	0.0227	CbGeAlD
Liotrix—Nausea—Pravastatin—atherosclerosis	0.00018	0.00189	CcSEcCtD
Liotrix—ABCB1—blood vessel—atherosclerosis	0.000179	0.0225	CbGeAlD
Liotrix—Liothyronine—ALB—atherosclerosis	0.000176	0.416	CrCbGaD
Liotrix—SLCO1A2—liver—atherosclerosis	0.000148	0.0185	CbGeAlD
Liotrix—ALB—liver—atherosclerosis	0.000147	0.0184	CbGeAlD
Liotrix—CYP2C8—liver—atherosclerosis	0.000103	0.013	CbGeAlD
Liotrix—ABCB1—cardiovascular system—atherosclerosis	8e-05	0.01	CbGeAlD
Liotrix—ABCB1—adipose tissue—atherosclerosis	7.06e-05	0.00886	CbGeAlD
Liotrix—ABCB1—liver—atherosclerosis	4.95e-05	0.00621	CbGeAlD
Liotrix—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.12e-05	0.000116	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.12e-05	0.000116	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—MTHFR—atherosclerosis	1.12e-05	0.000116	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CD36—atherosclerosis	1.12e-05	0.000116	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.12e-05	0.000115	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SERPINE1—atherosclerosis	1.11e-05	0.000114	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.1e-05	0.000114	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PPARA—atherosclerosis	1.1e-05	0.000113	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP27A1—atherosclerosis	1.1e-05	0.000113	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP27A1—atherosclerosis	1.09e-05	0.000112	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.08e-05	0.000111	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.08e-05	0.000111	CbGpPWpGaD
Liotrix—TTR—Disease—STAT3—atherosclerosis	1.08e-05	0.000111	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.07e-05	0.000111	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—FABP4—atherosclerosis	1.07e-05	0.000111	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—LCAT—atherosclerosis	1.07e-05	0.000111	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—HMOX1—atherosclerosis	1.07e-05	0.00011	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	1.07e-05	0.00011	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ABCA1—atherosclerosis	1.07e-05	0.00011	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AGT—atherosclerosis	1.07e-05	0.00011	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.06e-05	0.000109	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NOS3—atherosclerosis	1.06e-05	0.000109	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.05e-05	0.000109	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APOA4—atherosclerosis	1.05e-05	0.000108	CbGpPWpGaD
Liotrix—THRB—Gene Expression—AKT1—atherosclerosis	1.05e-05	0.000108	CbGpPWpGaD
Liotrix—THRA—Gene Expression—AKT1—atherosclerosis	1.05e-05	0.000108	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.05e-05	0.000108	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—APOE—atherosclerosis	1.04e-05	0.000108	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALOX15—atherosclerosis	1.04e-05	0.000107	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	1.04e-05	0.000107	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	1.04e-05	0.000107	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—APOA2—atherosclerosis	1.04e-05	0.000107	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	1.04e-05	0.000107	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CAV1—atherosclerosis	1.03e-05	0.000107	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALOX15—atherosclerosis	1.03e-05	0.000107	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALOX5AP—atherosclerosis	1.03e-05	0.000107	CbGpPWpGaD
Liotrix—ALB—Metabolism—APOA2—atherosclerosis	1.03e-05	0.000107	CbGpPWpGaD
Liotrix—ALB—Metabolism—PLA2G2A—atherosclerosis	1.03e-05	0.000107	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.03e-05	0.000107	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PDGFB—atherosclerosis	1.03e-05	0.000107	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—APOA1—atherosclerosis	1.03e-05	0.000106	CbGpPWpGaD
Liotrix—TTR—Disease—MAPK3—atherosclerosis	1.03e-05	0.000106	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCG5—atherosclerosis	1.03e-05	0.000106	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.03e-05	0.000106	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—APOB—atherosclerosis	1.03e-05	0.000106	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MMP1—atherosclerosis	1.02e-05	0.000105	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCG5—atherosclerosis	1.02e-05	0.000105	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.02e-05	0.000105	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.02e-05	0.000105	CbGpPWpGaD
Liotrix—TTR—Disease—TGFB1—atherosclerosis	9.98e-06	0.000103	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTM1—atherosclerosis	9.97e-06	0.000103	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—LPA—atherosclerosis	9.92e-06	0.000102	CbGpPWpGaD
Liotrix—ALB—Metabolism—LPA—atherosclerosis	9.87e-06	0.000102	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CAV1—atherosclerosis	9.8e-06	0.000101	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	9.79e-06	0.000101	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—LPL—atherosclerosis	9.79e-06	0.000101	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.78e-06	0.000101	CbGpPWpGaD
Liotrix—ALB—Hemostasis—APOA1—atherosclerosis	9.77e-06	0.000101	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	9.64e-06	9.94e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—BGN—atherosclerosis	9.61e-06	9.9e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP27A1—atherosclerosis	9.56e-06	9.85e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—BGN—atherosclerosis	9.55e-06	9.85e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GPX1—atherosclerosis	9.55e-06	9.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.54e-06	9.83e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—APOA5—atherosclerosis	9.51e-06	9.8e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	9.5e-06	9.79e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.49e-06	9.78e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—APOA5—atherosclerosis	9.46e-06	9.75e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CG—atherosclerosis	9.42e-06	9.71e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL8—atherosclerosis	9.37e-06	9.66e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	9.37e-06	9.66e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	9.36e-06	9.64e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—F2—atherosclerosis	9.32e-06	9.61e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CD36—atherosclerosis	9.3e-06	9.59e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.24e-06	9.52e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS2—atherosclerosis	9.21e-06	9.5e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.19e-06	9.47e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	9.16e-06	9.44e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—HMOX1—atherosclerosis	9.15e-06	9.43e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PLA2G1B—atherosclerosis	9.1e-06	9.38e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PPARG—atherosclerosis	9.1e-06	9.37e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APOA2—atherosclerosis	9.06e-06	9.34e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PLA2G2A—atherosclerosis	9.06e-06	9.34e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALOX15—atherosclerosis	9.06e-06	9.34e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALOX5AP—atherosclerosis	9.06e-06	9.34e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.05e-06	9.33e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	9.02e-06	9.3e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9e-06	9.28e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.97e-06	9.24e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ABCG5—atherosclerosis	8.95e-06	9.22e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.95e-06	9.22e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CG—atherosclerosis	8.92e-06	9.2e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—INS—atherosclerosis	8.92e-06	9.19e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.92e-06	9.19e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.9e-06	9.17e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALOX5—atherosclerosis	8.84e-06	9.11e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—MTHFR—atherosclerosis	8.81e-06	9.08e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALOX5—atherosclerosis	8.79e-06	9.06e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—APOB—atherosclerosis	8.77e-06	9.03e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	8.74e-06	9e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PPARA—atherosclerosis	8.65e-06	8.91e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—LPA—atherosclerosis	8.64e-06	8.91e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTM1—atherosclerosis	8.53e-06	8.79e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—atherosclerosis	8.48e-06	8.74e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	8.46e-06	8.72e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NFKB1—atherosclerosis	8.39e-06	8.64e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AGT—atherosclerosis	8.37e-06	8.63e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—BGN—atherosclerosis	8.37e-06	8.63e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—LPL—atherosclerosis	8.37e-06	8.63e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APOA5—atherosclerosis	8.29e-06	8.54e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK8—atherosclerosis	8.24e-06	8.5e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—APOE—atherosclerosis	8.2e-06	8.46e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ALB—atherosclerosis	8.18e-06	8.43e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.17e-06	8.42e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IGF1—atherosclerosis	8.17e-06	8.42e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GPX1—atherosclerosis	8.17e-06	8.42e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CAV1—atherosclerosis	8.13e-06	8.38e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.12e-06	8.37e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—APOA1—atherosclerosis	8.11e-06	8.36e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PLA2G1B—atherosclerosis	7.98e-06	8.22e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CD36—atherosclerosis	7.95e-06	8.2e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NAMPT—atherosclerosis	7.93e-06	8.17e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.9e-06	8.14e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NAMPT—atherosclerosis	7.89e-06	8.13e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.89e-06	8.13e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—LIPC—atherosclerosis	7.88e-06	8.12e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.84e-06	8.08e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—LIPC—atherosclerosis	7.84e-06	8.08e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—APOC3—atherosclerosis	7.83e-06	8.07e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—NOS3—atherosclerosis	7.82e-06	8.06e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—APOC3—atherosclerosis	7.79e-06	8.03e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—LDLR—atherosclerosis	7.79e-06	8.02e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SERPINE1—atherosclerosis	7.76e-06	8e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—LDLR—atherosclerosis	7.74e-06	7.98e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALOX5—atherosclerosis	7.7e-06	7.94e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—atherosclerosis	7.61e-06	7.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CETP—atherosclerosis	7.6e-06	7.84e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CETP—atherosclerosis	7.56e-06	7.79e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—MTHFR—atherosclerosis	7.54e-06	7.77e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STAT3—atherosclerosis	7.54e-06	7.77e-05	CbGpPWpGaD
Liotrix—TTR—Disease—IL6—atherosclerosis	7.52e-06	7.75e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.41e-06	7.64e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS3—atherosclerosis	7.41e-06	7.63e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CG—atherosclerosis	7.4e-06	7.63e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PPARA—atherosclerosis	7.39e-06	7.62e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SCARB1—atherosclerosis	7.28e-06	7.51e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SCARB1—atherosclerosis	7.24e-06	7.46e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK3—atherosclerosis	7.2e-06	7.42e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AGT—atherosclerosis	7.16e-06	7.38e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—atherosclerosis	7.16e-06	7.37e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PPARG—atherosclerosis	7.15e-06	7.37e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.09e-06	7.31e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—APOE—atherosclerosis	7.02e-06	7.23e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—INS—atherosclerosis	7.01e-06	7.22e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TGFB1—atherosclerosis	6.99e-06	7.2e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CAV1—atherosclerosis	6.95e-06	7.16e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—APOA1—atherosclerosis	6.94e-06	7.15e-05	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—atherosclerosis	6.94e-06	7.15e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NAMPT—atherosclerosis	6.91e-06	7.12e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HMGCR—atherosclerosis	6.88e-06	7.09e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—LIPC—atherosclerosis	6.87e-06	7.08e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HMGCR—atherosclerosis	6.84e-06	7.05e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APOC3—atherosclerosis	6.82e-06	7.03e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—LDLR—atherosclerosis	6.78e-06	6.99e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CETP—atherosclerosis	6.63e-06	6.83e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	6.61e-06	6.81e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.5e-06	6.7e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALB—atherosclerosis	6.43e-06	6.62e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SCARB1—atherosclerosis	6.34e-06	6.54e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	6.33e-06	6.53e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.2e-06	6.39e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.17e-06	6.36e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NOS3—atherosclerosis	6.15e-06	6.33e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCA1—atherosclerosis	6.13e-06	6.32e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PPARG—atherosclerosis	6.11e-06	6.3e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCA1—atherosclerosis	6.09e-06	6.28e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—INS—atherosclerosis	5.99e-06	6.18e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HMGCR—atherosclerosis	5.99e-06	6.17e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	5.87e-06	6.05e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—atherosclerosis	5.74e-06	5.92e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—atherosclerosis	5.62e-06	5.79e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALB—atherosclerosis	5.5e-06	5.66e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ABCA1—atherosclerosis	5.34e-06	5.5e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—atherosclerosis	5.34e-06	5.5e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6—atherosclerosis	5.26e-06	5.43e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HMOX1—atherosclerosis	5.26e-06	5.42e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NOS3—atherosclerosis	5.26e-06	5.42e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HMOX1—atherosclerosis	5.23e-06	5.39e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MAPK3—atherosclerosis	5.05e-06	5.2e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—APOB—atherosclerosis	5.04e-06	5.19e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—APOB—atherosclerosis	5.01e-06	5.16e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTM1—atherosclerosis	4.9e-06	5.05e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TGFB1—atherosclerosis	4.9e-06	5.05e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTM1—atherosclerosis	4.87e-06	5.02e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—atherosclerosis	4.86e-06	5e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—LPL—atherosclerosis	4.81e-06	4.96e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—atherosclerosis	4.81e-06	4.95e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—LPL—atherosclerosis	4.78e-06	4.93e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GPX1—atherosclerosis	4.69e-06	4.84e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GPX1—atherosclerosis	4.67e-06	4.81e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HMOX1—atherosclerosis	4.58e-06	4.72e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CD36—atherosclerosis	4.57e-06	4.71e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CD36—atherosclerosis	4.54e-06	4.68e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APOB—atherosclerosis	4.39e-06	4.52e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MTHFR—atherosclerosis	4.33e-06	4.46e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—MTHFR—atherosclerosis	4.31e-06	4.44e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTM1—atherosclerosis	4.27e-06	4.4e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPARA—atherosclerosis	4.25e-06	4.38e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPARA—atherosclerosis	4.22e-06	4.35e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—LPL—atherosclerosis	4.19e-06	4.32e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AGT—atherosclerosis	4.11e-06	4.24e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AGT—atherosclerosis	4.09e-06	4.22e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GPX1—atherosclerosis	4.09e-06	4.21e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—APOE—atherosclerosis	4.03e-06	4.16e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—APOE—atherosclerosis	4.01e-06	4.13e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CAV1—atherosclerosis	3.99e-06	4.12e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—APOA1—atherosclerosis	3.99e-06	4.11e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CD36—atherosclerosis	3.98e-06	4.1e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CAV1—atherosclerosis	3.97e-06	4.09e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—APOA1—atherosclerosis	3.96e-06	4.08e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTHFR—atherosclerosis	3.77e-06	3.89e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPARA—atherosclerosis	3.7e-06	3.81e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CG—atherosclerosis	3.64e-06	3.75e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CG—atherosclerosis	3.62e-06	3.73e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—atherosclerosis	3.6e-06	3.71e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AGT—atherosclerosis	3.58e-06	3.69e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APOE—atherosclerosis	3.51e-06	3.62e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPARG—atherosclerosis	3.51e-06	3.62e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPARG—atherosclerosis	3.49e-06	3.6e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CAV1—atherosclerosis	3.48e-06	3.59e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APOA1—atherosclerosis	3.47e-06	3.58e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—INS—atherosclerosis	3.44e-06	3.55e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—INS—atherosclerosis	3.42e-06	3.53e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—atherosclerosis	3.41e-06	3.51e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.17e-06	3.27e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALB—atherosclerosis	3.16e-06	3.25e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPARG—atherosclerosis	3.06e-06	3.15e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NOS3—atherosclerosis	3.02e-06	3.11e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NOS3—atherosclerosis	3e-06	3.1e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—INS—atherosclerosis	3e-06	3.09e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—atherosclerosis	2.83e-06	2.91e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—atherosclerosis	2.76e-06	2.85e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALB—atherosclerosis	2.75e-06	2.84e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—atherosclerosis	2.75e-06	2.83e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NOS3—atherosclerosis	2.63e-06	2.71e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—atherosclerosis	2.42e-06	2.49e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—atherosclerosis	2.41e-06	2.48e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—atherosclerosis	1.39e-06	1.43e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—atherosclerosis	1.38e-06	1.42e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—atherosclerosis	1.21e-06	1.25e-05	CbGpPWpGaD
